{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:53:48Z","timestamp":1775822028170,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Regeneron Pharmaceuticals and Sanofi"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular disease (CVD) remains the leading cause of premature death in England, with ethnic minority populations disproportionately affected, largely due to differences in socioeconomic factors, exposure and\/or susceptibility to CVD risk factors. Midlife risk assessment does not fully account for observed variation in CVD incidence and mortality. Early and precise quantification of risk factor burden across diverse populations is therefore essential to inform targeted prevention strategies. This study assessed the prevalence of CVD risk factors in apparently healthy individuals residing in London.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included CVD-free individuals aged 30\u201390\u00a0years residing in London and registered with general practices using the Egton Medical Information Systems (EMIS) electronic health record system. Unadjusted, crude estimates of traditional CVD risk factors were assessed across participants of different ethnicities who underwent a CVD risk assessment between 2009\u20132020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 607,327 registered individuals, 83,414 were included (52.0% women, median age 45 [IQR:36\u201348] years). Ethnic distribution was as follows: White (43.6%), Asian (30.1%), Black (9.7%), Chinese\/Other (4.0%), Mixed (2.1%). Overall, 7.8% were current smokers, 31.5% had obesity (universally defined as body mass index (BMI)\u2009\u2265\u200930.0\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ), 48.5% had elevated blood pressure (BP\u2009\u2265\u2009140\/90\u00a0mmHg), 44.9% had hypercholesterolemia (\u2265\u20095.0\u00a0mmol\/l), 28.2% had elevated triglycerides (TG)\u2009\u2265\u20091.7\u00a0mmol\/l, and 25.9% had low high-density lipoprotein cholesterol (HDL-C\u2009&lt;\u20091.0\/1.3\u00a0mmol\/l for males\/females, respectively). Smoking prevalence was highest among White individuals (9.7%). Obesity prevalence varied across groups, with higher proportions in Black participants (42.3%) and lower in Asian individuals (26.1%). Elevated BP was recorded more frequently in Mixed (54.9%) and Black (53.0%) participants and less frequently in those classified as Chinese\/Other (42.7%). Total cholesterol\u2009\u2265\u20095.0\u00a0mmol\/L was more commonly documented in Mixed (56.8%) and White (49.8%) participants. Higher proportions of Asian individuals had elevated TG (30.9%) and low HDL-C (31.6%), while corresponding proportions were lower among Black participants (14.4% and 19.5%, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This large-scale analysis of a diverse population suggests variation in CVD risk factor burden among relatively young individuals without CVD. While not implying causality, these findings reflect inequalities between ethnic groups and support an appraisal of early, tailored, and equitable public health policies to improve CVD risk management across diverse populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-04739-6","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:16:34Z","timestamp":1772579794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethnic differences in the burden of cardiovascular disease risk factors among adult residents of London: the TOGETHER study"],"prefix":"10.1186","volume":"24","author":[{"given":"Fotios","family":"Barkas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malo","family":"Dirou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanika I.","family":"Dharmayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Mazidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio J.","family":"Vallejo-Vaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe A. T.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany","family":"Elshorbagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"8","key":"4739_CR1","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024;149(8):e347\u2013913.","journal-title":"Circulation"},{"key":"4739_CR2","unstructured":"Foundation BH: heart & circulatory disease statistics 2024. Assessed from https:\/\/www.bhf.org.uk\/what-we-do\/our-research\/heart-statistics\/heart-statistics-publications on 22 May 2025. 2025."},{"issue":"10","key":"4739_CR3","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1093\/cvr\/cvac053","volume":"118","author":"KM Cheema","year":"2022","unstructured":"Cheema KM, Dicks E, Pearson J, Samani NJ. Long-term trends in the epidemiology of cardiovascular diseases in the UK: insights from the British Heart Foundation statistical compendium. Cardiovasc Res. 2022;118(10):2267\u201380.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4739_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-022-02079-z","volume":"11","author":"M Patel","year":"2022","unstructured":"Patel M, Abatcha S, Uthman O. Ethnic differences between South Asians and White Caucasians in cardiovascular disease-related mortality in developed countries: a systematic literature review. Syst Rev. 2022;11(1):207.","journal-title":"Syst Rev"},{"issue":"1","key":"4739_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02337-w","volume":"20","author":"FK Ho","year":"2022","unstructured":"Ho FK, Gray SR, Welsh P, Gill JMR, Sattar N, Pell JP, et al. Ethnic differences in cardiovascular risk: examining differential exposure and susceptibility to risk factors. BMC Med. 2022;20(1):149.","journal-title":"BMC Med"},{"issue":"2","key":"4739_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0021-9150(98)00239-1","volume":"142","author":"CJ Whitty","year":"1999","unstructured":"Whitty CJ, Brunner EJ, Shipley MJ, Hemingway H, Marmot MG. Differences in biological risk factors for cardiovascular disease between three ethnic groups in the Whitehall II study. Atherosclerosis. 1999;142(2):279\u201386.","journal-title":"Atherosclerosis"},{"issue":"2","key":"4739_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2337\/dc12-0544","volume":"36","author":"T Tillin","year":"2013","unstructured":"Tillin T, Hughes AD, Godsland IF, Whincup P, Forouhi NG, Welsh P, et al. Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort. Diabetes Care. 2013;36(2):383\u201393.","journal-title":"Diabetes Care"},{"issue":"17","key":"4739_CR8","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jacc.2012.12.046","volume":"61","author":"T Tillin","year":"2013","unstructured":"Tillin T, Hughes AD, Mayet J, Whincup P, Sattar N, Forouhi NG, et al. The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) - - a prospective population-based study. J Am Coll Cardiol. 2013;61(17):1777\u201386.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4739_CR9","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/ije\/dyaa135","volume":"49","author":"S Jones","year":"2020","unstructured":"Jones S, Tillin T, Park C, Williams S, Rapala A, Al Saikhan L, et al. Cohort profile update: Southall and Brent Revisited (SABRE) study: a UK population-based comparison of cardiovascular disease and diabetes in people of European, South Asian and African Caribbean heritage. Int J Epidemiol. 2020;49(5):1441\u20131442e.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"4739_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003485","volume":"3","author":"RS Bhopal","year":"2013","unstructured":"Bhopal RS, Humphry RW, Fischbacher CM. Changes in cardiovascular risk factors in relation to increasing ethnic inequalities in cardiovascular mortality: comparison of cross-sectional data in the health surveys for England 1999 and 2004. BMJ Open. 2013;3(9):e003485.","journal-title":"BMJ Open"},{"issue":"1","key":"4739_CR11","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/j.atherosclerosis.2007.02.017","volume":"195","author":"P Zaninotto","year":"2007","unstructured":"Zaninotto P, Mindell J, Hirani V. Prevalence of cardiovascular risk factors among ethnic groups: results from the health surveys for England. Atherosclerosis. 2007;195(1):e48-57.","journal-title":"Atherosclerosis"},{"issue":"2","key":"4739_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0001560","volume":"3","author":"KK Lee","year":"2023","unstructured":"Lee KK, Norris ET, Rishishwar L, Conley AB, Marino-Ramirez L, McDonald JF, et al. Ethnic disparities in mortality and group-specific risk factors in the UK Biobank. PLoS Glob Public Health. 2023;3(2):e0001560.","journal-title":"PLoS Glob Public Health"},{"issue":"6","key":"4739_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.052430","volume":"144","author":"AP Patel","year":"2021","unstructured":"Patel AP, Wang M, Kartoun U, Ng K, Khera AV. Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals: results from the UK Biobank prospective cohort study. Circulation. 2021;144(6):410\u201322.","journal-title":"Circulation"},{"issue":"6","key":"4739_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178945","volume":"12","author":"J George","year":"2017","unstructured":"George J, Mathur R, Shah AD, Pujades-Rodriguez M, Denaxas S, Smeeth L, et al. Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: associations in a linked electronic health record cohort of 1 million patients. PLoS One. 2017;12(6):e0178945.","journal-title":"PLoS One"},{"issue":"9","key":"4739_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003415","volume":"3","author":"N Bansal","year":"2013","unstructured":"Bansal N, Fischbacher CM, Bhopal RS, Brown H, Steiner MF, Capewell S, et al. Myocardial infarction incidence and survival by ethnic group: Scottish Health and Ethnicity Linkage retrospective cohort study. BMJ Open. 2013;3(9):e003415.","journal-title":"BMJ Open"},{"key":"4739_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2147\/CLEP.S227621","volume":"11","author":"TM Pham","year":"2019","unstructured":"Pham TM, Carpenter JR, Morris TP, Sharma M, Petersen I. Ethnic differences in the prevalence of type 2 diabetes diagnoses in the UK: cross-sectional analysis of the health improvement network primary care database. Clin Epidemiol. 2019;11:1081\u20138.","journal-title":"Clin Epidemiol"},{"key":"4739_CR17","volume":"7","author":"E Dal Canto","year":"2018","unstructured":"Dal Canto E, Farukh B, Faconti L. Why are there ethnic differences in cardio-metabolic risk factors and cardiovascular diseases? JRSM Cardiovasc Dis. 2018;7:2048004018818923.","journal-title":"JRSM Cardiovasc Dis"},{"key":"4739_CR18","unstructured":"England PH: NHS Health Check Programme Best Practice Guidance. In.; 2019: https:\/\/www.healthcheck.nhs.uk\/commissioners-and-providers\/national-guidance\/ Accessed 11 November 2023."},{"key":"4739_CR19","doi-asserted-by":"crossref","unstructured":"Krogsb\u00f8ll Lasse T, J\u00f8rgensen Karsten J, Gr\u00f8nh\u00f8j Larsen C, G\u00f8tzsche Peter C: General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev. 2012;10:CD009009.","DOI":"10.1002\/14651858.CD009009.pub2"},{"issue":"8","key":"4739_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000320","volume":"7","author":"S Capewell","year":"2010","unstructured":"Capewell S, Graham H. Will cardiovascular disease prevention widen health inequalities? PLoS Med. 2010;7(8):e1000320.","journal-title":"PLoS Med"},{"issue":"2","key":"4739_CR21","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1093\/pubmed\/fdx068","volume":"40","author":"MC Gulliford","year":"2018","unstructured":"Gulliford MC, Khoshaba B, McDermott L, Cornelius V, Ashworth M, Fuller F, et al. Cardiovascular risk at health checks performed opportunistically or following an invitation letter. Cohort study. J Public Health. 2018;40(2):e151\u20136.","journal-title":"J Public Health"},{"issue":"710","key":"4739_CR22","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.3399\/BJGP.2020.0887","volume":"71","author":"N Gold","year":"2021","unstructured":"Gold N, Tan K, Sherlock J, Watson R, Chadborn T. Increasing uptake of NHS health checks: a randomised controlled trial using GP computer prompts. Br J Gen Pract. 2021;71(710):e693\u2013700.","journal-title":"Br J Gen Pract"},{"key":"4739_CR23","doi-asserted-by":"publisher","DOI":"10.1017\/S1463423618000592","volume":"20","author":"VA Riley","year":"2018","unstructured":"Riley VA, Gidlow C, Ellis NJ. Uptake of NHS health check: issues in monitoring. Prim Health Care Res Dev. 2018;20:e64.","journal-title":"Prim Health Care Res Dev"},{"issue":"14","key":"4739_CR24","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","volume":"389","author":"C Magnussen","year":"2023","unstructured":"Global Cardiovascular Risk C, Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, et al. Global effect of modifiable risk factors on cardiovascular disease and mortality. N Engl J Med. 2023;389(14):1273\u201385.","journal-title":"N Engl J Med"},{"issue":"10","key":"4739_CR25","doi-asserted-by":"publisher","DOI":"10.2196\/17548","volume":"9","author":"K Dharmayat","year":"2020","unstructured":"Dharmayat K, Woringer M, Mastellos N, Cole D, Car J, Ray S, et al. Investigation of cardiovascular health and risk factors among the diverse and contemporary population in London (the TOGETHER study): protocol for linking longitudinal medical records. JMIR Res Protoc. 2020;9(10):e17548.","journal-title":"JMIR Res Protoc"},{"key":"4739_CR26","unstructured":"World Health Organization. WHO factsheets: obesity and overweight 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed 12 Nov 2023."},{"issue":"12","key":"4739_CR27","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens"},{"issue":"1","key":"4739_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"issue":"4","key":"4739_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10055-025-01222-0","volume":"29","author":"IA Aguilar","year":"2025","unstructured":"Aguilar IA, Suomalainen M, LaValle SM, Ojala T, Riecke BE. From \u201cskype on wheels\u201d to embodied telepresence: a holistic approach to improving the user experience of telepresence robots. Virtual Reality. 2025;29(4):161.","journal-title":"Virtual Reality"},{"issue":"20","key":"4739_CR30","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical A","year":"2013","unstructured":"World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"issue":"6","key":"4739_CR31","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/eurpub\/ckad146","volume":"33","author":"L Ng Fat","year":"2023","unstructured":"Ng Fat L, Patil P, Mindell JS, Manikam L, Scholes S. Ethnic differences in multimorbidity after accounting for social-economic factors, findings from the health survey for England. Eur J Public Health. 2023;33(6):959\u201367.","journal-title":"Eur J Public Health"},{"issue":"11","key":"4739_CR32","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1016\/j.numecd.2022.08.002","volume":"32","author":"C Razieh","year":"2022","unstructured":"Razieh C, Zaccardi F, Miksza J, Davies MJ, Hansell AL, Khunti K, et al. Differences in the risk of cardiovascular disease across ethnic groups: UK Biobank observational study. Nutr Metab Cardiovasc Dis. 2022;32(11):2594\u2013602.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"4739_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.121.007917","volume":"15","author":"Z Javed","year":"2022","unstructured":"Javed Z, Haisum Maqsood M, Yahya T, Amin Z, Acquah I, Valero-Elizondo J, et al. Race, racism, and cardiovascular health: applying a social determinants of health framework to racial\/ethnic disparities in cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2022;15(1):e007917.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"4739_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/heartjnl-2013-304474","volume":"100","author":"T Tillin","year":"2014","unstructured":"Tillin T, Hughes AD, Whincup P, Mayet J, Sattar N, McKeigue PM, et al. Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall and Brent REvisited). Heart. 2014;100(1):60\u20137.","journal-title":"Heart"},{"issue":"9438","key":"4739_CR35","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937\u201352.","journal-title":"Lancet"},{"issue":"1","key":"4739_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000765","volume":"7","author":"M Muilwijk","year":"2019","unstructured":"Muilwijk M, Ho F, Waddell H, Sillars A, Welsh P, Iliodromiti S, et al. Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the UK Biobank population-based cohort study. BMJ Open Diabetes Res Care. 2019;7(1):e000765.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"23","key":"4739_CR37","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1136\/heartjnl-2013-304625","volume":"99","author":"J Baker","year":"2013","unstructured":"Baker J, Mitchell R, Lawson K, Pell J. Ethnic differences in the cost-effectiveness of targeted and mass screening for high cardiovascular risk in the UK: cross-sectional study. Heart. 2013;99(23):1766\u201371.","journal-title":"Heart"},{"issue":"9","key":"4739_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029420","volume":"9","author":"O Kennedy","year":"2019","unstructured":"Kennedy O, Su F, Pears R, Walmsley E, Roderick P. Evaluating the effectiveness of the NHS health check programme in South England: a quasi-randomised controlled trial. BMJ Open. 2019;9(9):e029420.","journal-title":"BMJ Open"},{"issue":"2","key":"4739_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052832","volume":"12","author":"L Tanner","year":"2022","unstructured":"Tanner L, Kenny R, Still M, Ling J, Pearson F, Thompson K, et al. NHS health check programme: a rapid review update. BMJ Open. 2022;12(2):e052832.","journal-title":"BMJ Open"},{"key":"4739_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101471","volume":"49","author":"M Molokhia","year":"2022","unstructured":"Molokhia M, Ayis DS, Karamanos A, L\u2019Esperance DV, Yousif S, Durbaba S, et al. What factors influence differential uptake of NHS Health Checks, diabetes and hypertension reviews among women in ethnically diverse South London? Cross-sectional analysis of 63,000 primary care records. EClinicalMedicine. 2022;49:101471.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"4739_CR41","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.amepre.2020.07.027","volume":"60","author":"L Tuzzio","year":"2021","unstructured":"Tuzzio L, O\u2019Meara ES, Holden E, Parchman ML, Ralston JD, Powell JA, et al. Barriers to implementing cardiovascular risk calculation in primary care: alignment with the consolidated framework for implementation research. Am J Prev Med. 2021;60(2):250\u20137.","journal-title":"Am J Prev Med"},{"issue":"7","key":"4739_CR42","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41366-024-01514-6","volume":"48","author":"M Kasher Meron","year":"2024","unstructured":"Kasher Meron M, Eizenstein S, Cukierman-Yaffe T, Oieru D. Missed diagnosis-a major barrier to patient access to obesity healthcare in the primary care setting. Int J Obes (Lond). 2024;48(7):1003\u201310.","journal-title":"Int J Obes (Lond)"},{"issue":"7","key":"4739_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.20498","volume":"8","author":"Y Lu","year":"2025","unstructured":"Lu Y, Brush JE Jr, Kim C, Liu Y, Xin X, Huang C, et al. Delayed hypertension diagnosis and its association with cardiovascular treatment and outcomes. JAMA Netw Open. 2025;8(7):e2520498.","journal-title":"JAMA Netw Open"},{"key":"4739_CR44","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.19470.1","volume":"8","author":"RW Aldridge","year":"2023","unstructured":"Aldridge RW, Evans HER, Yavlinsky A, Moayyeri A, Bhaskaran K, Mathur R, et al. Estimating disease burden using national linked electronic health records: a study using an English population-based cohort. Wellcome Open Res. 2023;8:262.","journal-title":"Wellcome Open Res"},{"issue":"9","key":"4739_CR45","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026\u201334.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"4739_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-024-02958-1","volume":"11","author":"M Pineda-Moncusi","year":"2024","unstructured":"Pineda-Moncusi M, Allery F, Delmestri A, Bolton T, Nolan J, Thygesen JH, et al. Ethnicity data resource in population-wide health records: completeness, coverage and granularity of diversity. Sci Data. 2024;11(1):221.","journal-title":"Sci Data"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04739-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04739-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04739-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:03:58Z","timestamp":1775819038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04739-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4739"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04739-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The TOGETHER study protocol received ethical approval (Ref: 17-ES-0104) from the Joint Research Compliance Office and the Imperial College Research Ethics Committee (Imperial College London, UK). Participation by general practices required Research and Development (R&D) approval from the respective NHS Trusts. The study adhered to the ethical principles of the Declaration of Helsinki. Consent to release patient-level data was sought directly from participating GPs. Upon receiving consent to participate in research, patient-level data were extracted directly from the central EMIS data warehouse.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved the final version of the manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"F. Barkas has received research grants from Amgen, Boehringer Ingelheim, Eli Lilly, Novartis, Novo Nordisk and honoraria from Menarini Hellas, Novartis, Novo Nordisk, Sanofi and Viatris. A.J. Vallejo\u2010Vaz reports past or current participation in research grants to Imperial College London from Pfizer, Amgen, Merck Sharp & Dohme, Sanofi, Daiichi Sankyo, and Regeneron, outside the submitted work; personal fees for consulting from Bayer and Regeneron outside the submitted work; and acknowledges support from the Programme \u201cBeatriz Galindo\u201d from the Ministry of Universities, Spain, and University of Seville, Spain. C.A.T Stevens reports grants from Pfizer, Amgen, Merck Sharp & Dohme, Novartis, Sanofi, Daiichi Sankyo, and Regeneron, during the conduct of the study. K. Ray reports research grants from Amgen, Amarin, Sanofi, Daiichi-Sankyo, and Ultragenyx to Imperial College London; consultant fees from Novartis, Daiichi-Sankyo, Kowa, Esperion, Novo Nordisk, MSD, Eli Lilly, Silence Therapeutics, AstraZeneca, NewAmsterdam Pharma, Bayer, Beren Therapeutics, Cleerly, EmendoBio, Scribe, Nodthera, Crispr, Vaxxinity, and Sanofi; lecture fees from Novartis, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Viatris, Amarin, Sanofi, Amgen, Esperion, Daiichi-Sankyo, Dr. Reddys, and Mankind; fees from Macleod Pharma for symposia at international meetings; stock options in NewAmsterdam Pharma, Scribe Therapeutics, and Pemi31; and serving as past EAS President (unpaid). All other authors declare that they have no competing interests. Funding: The TOGETHER study was supported through investigator-initiated research grants to the Imperial College London from Regeneron Pharmaceuticals and Sanofi.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}